← Eichor
Study identifier: NCT04646707 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Erector Spinae (ESP) Block on Opioid Reduction and Enhanced Recovery After Posterior Cervical Spine Surgery

Condition: Postoperative · Pain  ·  Sponsor: University Health Network, Toronto

PhaseNA
Planned participants52
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Patients undergoing spine surgery frequently experience significant pain after surgery. This can limit patient activity and hinder rehabilitation. If inadequately treated, severe pain can result in emotional and psychological distress and ultimately impact long-term function, and increase the risk of developing pain that lasts longer than six months associated with depression, anxiety and disability. More specifically, Erector Spinae Plane (ESP) block is a recently described plane block designed to block the dorsal and ventral rami of the thoracic spinal nerves. It has shown to be an effective modality for postoperative pain management as a part of multimodal analgesia in spinal surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Michael Dinsmore, MD  ·  416 603 5800  ·  michael.dinsmore@uhn.ca

Ki Jinn Chin, MD  ·  416 603 5800

Always discuss trial participation with your own doctor first.

Locations (1)

Toronto Western Hospital?UHNToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04646707